VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹264 Cr | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹264 Cr |
| Mar2024 | ₹267 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹301 Cr |
| Mar2021 | ₹322 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹264 Cr | -1.23 | |
| Mar2024 | ₹267 Cr | -3.93 | |
| Mar2023 | ₹278 Cr | -7.59 | |
| Mar2022 | ₹301 Cr | -6.44 | |
| Mar2021 | ₹322 Cr | - | |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,451.2 Cr | 13% | 3% | 205.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 13% |
3% |
205.5% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses